Purified Protein Derivative (PPD)
Showing 1 - 25 of 9,549
Latent Tuberculosis Infection Trial (Recombinant Mycobacterium Tuberculosis Fusion Protein, Purified Protein Derivative of
Not yet recruiting
- Latent Tuberculosis Infection
- Recombinant Mycobacterium Tuberculosis Fusion Protein
- Purified Protein Derivative of Tuberculin
- (no location specified)
Jun 8, 2023
Healthy, Latent Tuberculosis Infection (LTBI) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Tuberculin
Recruiting
- Healthy
- Latent Tuberculosis Infection (LTBI)
- Tuberculin Purified Protein Derivative
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 22, 2022
Common Wart Trial (Tuberculin purified protein derivative)
Unknown status
- Common Wart
- Tuberculin purified protein derivative
- (no location specified)
Feb 26, 2020
Tuberculosis Trial in Shanghai (Placebo, Low dose adjuvant, High dose adjuvant)
Completed
- Tuberculosis
- Placebo
- +4 more
-
Shanghai, Shanghai, ChinaShanghai Public Health clinical Center
Mar 9, 2022
Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts Trial in Zagazig (Intralesional antigen
Completed
- Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts
- Intralesional antigen immunotherapy
-
Zagazig, Sharkia, EgyptZagazig university
Feb 14, 2022
Transitional Cell Carcinoma Trial in New York (TICE®-strain BCG, NY-ESO-1 protein, sargramostim)
Completed
- Transitional Cell Carcinoma
- TICE®-strain BCG
- +2 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Oct 3, 2022
Latent Tuberculosis Infection Trial (Recombinant Mycobacterium tuberculosis fusion protein for injection, TB-PPD was injected)
Not yet recruiting
- Latent Tuberculosis Infection
- Recombinant Mycobacterium tuberculosis fusion protein for injection
- TB-PPD was injected
- (no location specified)
Feb 16, 2023
Methods in People Living With Retroviral Infection in Liberia
Active, not recruiting
- Tuberculosis
- HIV
-
Bethesda, Maryland
- +4 more
Jan 14, 2023
HIV, Tuberculosis Trial in United States (Isoniazid, Pyrazinamide, Pyridoxine HCl)
Completed
- HIV Infections
- Tuberculosis
- Isoniazid
- +3 more
-
San Francisco, California
- +24 more
Oct 26, 2021
Tuberculosis Trial in Wuhan (Low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02), Low-dose adjuvant for
Completed
- Tuberculosis
- Low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02)
- +2 more
-
Wuhan, Hubei, ChinaWuhan Infectious Disease Hospital
Sep 2, 2022
Delayed Type Hypersensitivity Trial in Montreal (Prednisone, Placebo)
Completed
- Delayed Type Hypersensitivity
- Prednisone
- Placebo
-
Montreal, Quebec, CanadaInnovaderm Research Inc.
Jul 16, 2020
Tuberculosis Trial in Chendu (BCG vaccine 1(0.025mg/0.1ml/person), BCG vaccine 2 (0.05mg/0.1ml/person), BCG vaccine
Recruiting
- Tuberculosis
- BCG vaccine 1（0.025mg/0.1ml/person）
- +4 more
-
Chendu, Sichuan, ChinaSichuan Center for Disease Control and Prevention
Sep 1, 2022
Intralesional Versus Intramuscular Hepatitis B Vaccine for Multiple Common Warts Trial in Zagazig (hepatitis B vaccine
Completed
- Intralesional Versus Intramuscular Hepatitis B Vaccine for Multiple Common Warts
- hepatitis B vaccine immunotherapy of common warts (GeneVac-B 10 ml vial, Serum Institute of India Ltd., Pune, India)
- Intralesional saline
-
Zagazig, Sharkia, EgyptZagazig university
Apr 12, 2022
Malnutrition, Diabetes Mellitus, and Helminth Infections on
Active, not recruiting
- Mycobacterium Tuberculosis
- +4 more
-
Chennai, IndiaNational Institute for Research In Tuberculosis, International C
Jul 28, 2022
Cutaneous Warts Trial (Hepatitis B Virus Vaccine(HBV))
Not yet recruiting
- Cutaneous Warts
- Hepatitis B Virus Vaccine(HBV)
- (no location specified)
Jun 13, 2023
HIV, Tuberculosis Trial in United States (Isoniazid, Pyridoxine HCl)
Completed
- HIV Infections
- Tuberculosis
- Isoniazid
- Pyridoxine hydrochloride
-
Los Angeles, California
- +13 more
Oct 27, 2021
Latent Tuberculosis, Persistent Infection, Mycobacterium Tuberculosis Trial in Malmö
Recruiting
- Latent Tuberculosis
- +2 more
-
Malmö, Skåne, SwedenSkåne University Hospital
Nov 10, 2022
Atopic Dermatitis Trial in London (Skin biopsy, Skin suction blister, Mantoux test)
Withdrawn
- Atopic Dermatitis
- Skin biopsy
- +2 more
-
London, United KingdomRoyal Free London NHS Foundation Trust
Apr 27, 2021
Warts Trial (topical methotrexate hydrogel 1% coupled with microneedling., Liquid nitrogen)
Not yet recruiting
- Warts
- topical methotrexate hydrogel 1% coupled with microneedling.
- Liquid nitrogen
- (no location specified)
Mar 18, 2022
Tuberculosis Trial (Bacillus Calmette - Guerin, of Bacillus Calmette - Guerin)
Completed
- Tuberculosis
- Bacillus Calmette - Guerin
- placebo of Bacillus Calmette - Guerin
- (no location specified)
Sep 29, 2020
Tuberculosis Trial (Intradermal BCG (bacillus calmette-guerin) vaccine AJV)
Not yet recruiting
- Tuberculosis
- Intradermal BCG (bacillus calmette-guerin) vaccine AJV
- (no location specified)
Apr 17, 2023
Filarial Infection on Immune Responses in Latent Tuberculosis
Completed
- Mycobacterium Infections
- +3 more
-
Bethesda, Maryland
- +1 more
Apr 19, 2021
CTCL, Mycosis Fungoides, Sezary Syndrome Trial in New York (Ritlecitinib)
Recruiting
- CTCL
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
May 18, 2023
Intrabony Periodontal Defect Trial in Mansoura (Freeze-dried bone allograft combined with Enamel Matrix derivative, Freeze-dried
Recruiting
- Intrabony Periodontal Defect
- Freeze-dried bone allograft combined with Enamel Matrix derivative
- Freeze-dried bone allograft
-
Mansoura, EgyptMansoura University
Sep 16, 2023